Neuburgh Advisers LLC Takes $44,000 Position in Invacare Co. (NYSE:IVC)

Neuburgh Advisers LLC bought a new stake in Invacare Co. (NYSE:IVC) during the 2nd quarter, HoldingsChannel.com reports. The firm bought 8,432 shares of the health services provider’s stock, valued at approximately $44,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of Montreal Can lifted its position in shares of Invacare by 86.0% in the second quarter. Bank of Montreal Can now owns 6,162 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 2,849 shares in the last quarter. BNP Paribas Arbitrage SA lifted its position in shares of Invacare by 126.1% in the first quarter. BNP Paribas Arbitrage SA now owns 7,100 shares of the health services provider’s stock valued at $59,000 after acquiring an additional 3,960 shares in the last quarter. Metropolitan Life Insurance Co NY purchased a new position in shares of Invacare in the first quarter valued at approximately $102,000. Nisa Investment Advisors LLC lifted its position in shares of Invacare by 16.6% in the second quarter. Nisa Investment Advisors LLC now owns 21,100 shares of the health services provider’s stock valued at $110,000 after acquiring an additional 3,000 shares in the last quarter. Finally, MetLife Investment Advisors LLC purchased a new position in shares of Invacare in the first quarter valued at approximately $142,000.

Shares of NYSE:IVC traded up $0.38 during midday trading on Friday, hitting $7.78. The company had a trading volume of 8,602 shares, compared to its average volume of 390,911. Invacare Co. has a twelve month low of $3.05 and a twelve month high of $16.50. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.90 and a quick ratio of 1.26. The stock has a market cap of $255.29 million, a price-to-earnings ratio of -5.93 and a beta of 2.03. The business’s 50-day simple moving average is $5.20 and its 200-day simple moving average is $6.48.

Invacare (NYSE:IVC) last posted its quarterly earnings results on Monday, August 5th. The health services provider reported ($0.31) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.03). Invacare had a negative net margin of 4.20% and a negative return on equity of 11.26%. The company had revenue of $235.90 million during the quarter, compared to analyst estimates of $238.32 million. During the same period in the prior year, the business posted ($0.41) EPS. Invacare’s revenue for the quarter was down 4.2% compared to the same quarter last year. As a group, sell-side analysts forecast that Invacare Co. will post -1.13 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Friday, October 11th will be issued a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 6.43%. The ex-dividend date is Thursday, October 10th. This is a boost from Invacare’s previous quarterly dividend of $0.01. Invacare’s dividend payout ratio (DPR) is currently -3.79%.

IVC has been the topic of several research reports. Zacks Investment Research downgraded Invacare from a “hold” rating to a “sell” rating in a research report on Friday. ValuEngine upgraded Invacare from a “sell” rating to a “hold” rating in a research report on Thursday, August 1st.

About Invacare

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company operates through Europe, North America/Home Medical Equipment, Institutional Products Group, and the Asia/Pacific segments.

Featured Article: Operating Income

Want to see what other hedge funds are holding IVC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invacare Co. (NYSE:IVC).

Institutional Ownership by Quarter for Invacare (NYSE:IVC)

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit